Dr Ezra Aksoy
Lecturer
The William Harvey Research Institute
Queen Mary University of London
Queen Mary University of London
Research
intestinal immunity, intestinal repair and regeneration, host-microbiome interactions, nutrient sensing pathways, phosphoinositol 3-kinase biology, inflammasome
Interests
Our group is seeking cell signalling targets as biomarkers in immune and epithelial cells in the intestine that impact immune inflammation and regeneration processes. We use in vitro and ex vivo models to test and identify new drug targets associated with process driven inflammation and immune responses.Grants
Dissecting the antibacterial functions of Campylobacter Type VI Secretion System and effectorsEzra Aksoy
£200,228 Biotechnology and Biological Sciences Research Council
01-03-2025 - 29-02-2028
Uncovering selective role of PI3K signalling in antigen cross presentation in the phagosomeEzra Aksoy
£11,630 Royal Society
01-04-2022 - 31-03-2025
Unravelling Covid-19 immune responses in gut epithelium to target as potential site of immunisationEzra Aksoy
£10,000 February Foundation, The
01-08-2020 - 31-07-2021
Generation of a new stratification strategy based on a new biomarker assay for IBD therapyEzra Aksoy
£49,704 Barts and the London Charity
16-09-2019 - 31-01-2022
Signalling-in-NODS - ‘Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation’Ezra Aksoy
£156,364 EU Commission - Horizon 2020
01-05-2017 - 30-04-2019
The role and mechanism of action of p110delta P13K signalling in gastrointedtinal immunity and inflammationEzra Aksoy
£551,150 MRC Medical Research Council
01-06-2015 - 16-06-2019
The role and mechanism of action of p110delta P13K signalling in gastrointedtinal immunity and inflammationEzra Aksoy
£27,227 EU European Commission - Other
01-06-2015 - 14-12-2018